CeeLab Competitors

At Data Innovations, we believe that when we enable clinical labs of every size to harness innovation and optimize performance across all disciplines, we empower them to focus on what matters most: patient care. Our leading solutions, world-class service, and support for an open ecosystem transform lab enterprise management. Credited with establishing the lab enablement software space, Data Innovations serves more than 6,000 hospitals and laboratories in over 80 countries. Our end-to-end lab enablement solutions drive improved performance within and across labs, and include: • Industry-leading connectivity software that enables management of all connected LIS, LIMS and lab instruments across multiple sites and locations from a single dashboard • Connectivity management that maximizes lab uptime and data security with remote troubleshooting • Productivity solutions that enable you to optimize, automate, and standardize your lab • Quality control solutions that ensure accurate instrument performance for excellence in patient care • Automated compliance reporting that saves resource hours, speeds up reporting, and eliminates errors • Unparalleled customer support with the lab expertise and technical support to help your lab achieve its full potential It all adds up to enabling your lab to do more with less, perform better, and contribute to the best possible patient care.

StatLab Medical Products has been dedicated to helping anatomic pathology laboratories provide the best possible patient care since 1976. We offer an extensive portfolio of self-manufactured consumables and labeling and tracking equipment from nine manufacturing sites in the United States, United Kingdom, Germany, Spain, and Italy. Our global operational footprint powered by over 800 mission-driven colleagues delivers a dependable and resilient supply chain of high-quality products and solutions, and a customer-centric approach inspires us to deliver reliability, innovation, and quality in every interaction.

In 2022, TECHLAB was acquired by SSI Diagnostica Group. Today, TECHLAB functions as a brand under SSI Diagnostica Group. About SSI Diagnostica Group: SSI Diagnostica Group is a global in vitro diagnostics (IVD) company, specializing in infectious disease diagnostics. We employ staff and operate offices in Denmark, the United States, and China, with a total of eleven sites across three different continents. Each year, we deliver diagnostic solutions in more than 130 countries and manufacture more than 60 million diagnostic tests – helping people receive the right diagnosis and, ultimately, the right treatment as quickly as possible. Operating as one company today, SSI Diagnostica Group is historically the result of a series of acquisitions: SSI Diagnostica (2016), CTK Biotech (2020), Beijing Genesee Biotech (2020), Techlab (2022), Gulf Coast Scientific (2025), and InDevR (2026). Each brand has brought unique expertise and experience to the group, and as a combined company we offer more than 200 years of combined scientific expertise. SSID Group’s mission is to empower healthcare professionals to prevent, monitor, and diagnose infectious diseases – enabling better treatment outcomes for patients worldwide. SSI Diagnostica group has four disease focus areas: Gastric, Respiratory, Bloodborne, and general microbiology.